X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
animals (9) 9
antibodies (7) 7
article (7) 7
vaccines (7) 7
viruses (7) 7
macaca mulatta (6) 6
human immunodeficiency virus--hiv (5) 5
viral antibodies (5) 5
female (4) 4
health aspects (4) 4
hiv (4) 4
hiv-1 - immunology (4) 4
humans (4) 4
immunoglobulins (4) 4
infection (4) 4
infections (4) 4
monkeys (4) 4
multidisciplinary sciences (4) 4
simian immunodeficiency virus - immunology (4) 4
adenoviruses (3) 3
adoptive transfer (3) 3
antigens (3) 3
dna, viral - analysis (3) 3
dosage and administration (3) 3
genetic vectors (3) 3
hiv infection (3) 3
male (3) 3
medical research (3) 3
monkeys & apes (3) 3
neutralizing (3) 3
prevention (3) 3
proteins (3) 3
simian acquired immunodeficiency syndrome - therapy (3) 3
simian immunodeficiency virus - genetics (3) 3
viremia (3) 3
adenoviridae (2) 2
aids vaccines (2) 2
aids vaccines - immunology (2) 2
analysis (2) 2
antibodies, neutralizing - administration & dosage (2) 2
antibodies, neutralizing - immunology (2) 2
antibodies, viral - immunology (2) 2
antiretroviral agents (2) 2
antiretroviral drugs (2) 2
antiretroviral therapy (2) 2
cell biology (2) 2
clinical trials (2) 2
cross-reactivity (2) 2
dengue virus (2) 2
drug therapy (2) 2
effectiveness (2) 2
efficacy (2) 2
electric communication technique (2) 2
electricity (2) 2
hiv antibodies - administration & dosage (2) 2
hiv antibodies - immunology (2) 2
hiv infections - immunology (2) 2
hiv infections - therapy (2) 2
hiv-1 remission (2) 2
immune system (2) 2
immunity, cellular (2) 2
immunity, innate - immunology (2) 2
immunization (2) 2
immunology (2) 2
latent reservoir (2) 2
macaques (2) 2
medicine, research & experimental (2) 2
mice (2) 2
monoclonal-antibodies (2) 2
neutralizing antibodies (2) 2
persistence (2) 2
product development (2) 2
recombinant (2) 2
rna, viral - analysis (2) 2
saids vaccines - genetics (2) 2
saids vaccines - immunology (2) 2
simian acquired immunodeficiency syndrome - immunology (2) 2
simian immunodeficiency virus (2) 2
simian immunodeficiency virus - growth & development (2) 2
studies (2) 2
therapy (2) 2
toll-like receptor 7 - immunology (2) 2
transmission of digital information, e.g. telegraphiccommunication (2) 2
viral infections (2) 2
viral load (2) 2
viral vaccines (2) 2
abdominal pain - etiology (1) 1
abridged index medicus (1) 1
acquired immune deficiency syndrome--aids (1) 1
activation (1) 1
active antiretroviral therapy (1) 1
adenoviridae - genetics (1) 1
adenovirus vaccine vectors (1) 1
adolescent (1) 1
adult (1) 1
aids (1) 1
aids vaccines - administration & dosage (1) 1
aids vaccines - adverse effects (1) 1
aids vaccines - genetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunity, ISSN 1074-7613, 06/2017, Volume 46, Issue 6, pp. 1073 - 1088.e6
Journal Article
Science, ISSN 0036-8075, 09/2016, Volume 353, Issue 6304, pp. 1129 - 1132
Journal Article
Nature, ISSN 0028-0836, 12/2016, Volume 540, Issue 7632, pp. 284 - 287
The development of immunologic interventions that can target the viral reservoir in HIV-1-infected individuals is a major goal of HIV-1 research(1,2). However,... 
INDIVIDUALS | VIREMIA | PERSISTENCE | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | MACAQUES | LATENT RESERVOIR | T-CELLS | CHALLENGES | VIRAL RESERVOIR | HIV-1 REMISSION | AIDS Vaccines - immunology | Simian Immunodeficiency Virus - growth & development | DNA, Viral - analysis | Male | RNA, Viral - blood | Macaca mulatta | Vaccinia virus - genetics | Simian Immunodeficiency Virus - isolation & purification | HIV Infections - immunology | Simian Acquired Immunodeficiency Syndrome - virology | Simian Immunodeficiency Virus - genetics | Time Factors | Toll-Like Receptor 7 - immunology | Adenoviridae - genetics | Female | Simian Acquired Immunodeficiency Syndrome - therapy | Simian Immunodeficiency Virus - immunology | Toll-Like Receptor 7 - genetics | RNA, Viral - analysis | Immunity, Innate | Viral Load - immunology | Genetic Vectors - genetics | DNA, Viral - blood | SAIDS Vaccines - genetics | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Anti-Retroviral Agents - administration & dosage | HIV Infections - therapy | AIDS Vaccines - genetics | Immunity, Cellular | Prevention | TLR7 | Dosage and administration | Viral vaccines | Health aspects | HIV infection | Immunization | Adenoviruses | Human immunodeficiency virus--HIV | Viruses | Vaccines | Monkeys & apes | Viral infections
Journal Article
Science, ISSN 0036-8075, 09/2016, Volume 353, Issue 6303, pp. 1045 - 1049
Journal Article
Nature, ISSN 0028-0836, 11/2018, Volume 563, Issue 7731, pp. 360 - 364
The latent viral reservoir is the critical barrier for the development of a cure for HIV-1 infection. Previous studies have shown direct antiviral activity of... 
CELLS | VIREMIA | STIMULATION | EFFICACY | MULTIDISCIPLINARY SCIENCES | HUMANS | AIDS | LATENT RESERVOIR | HIV-1 REMISSION | Humans | Macaca mulatta - immunology | DNA, Viral - analysis | Male | Adoptive Transfer | CD8 Antigens - deficiency | Viral Load | Anti-HIV Agents - administration & dosage | Macaca mulatta - virology | Antibodies, Neutralizing - immunology | Simian Immunodeficiency Virus - genetics | Immunity, Cellular - drug effects | HIV Antibodies - immunology | Toll-Like Receptor 7 - immunology | Anti-HIV Agents - therapeutic use | Female | Simian Acquired Immunodeficiency Syndrome - therapy | Simian Immunodeficiency Virus - immunology | Toll-Like Receptor 7 - agonists | Pteridines - pharmacology | Immunity, Innate - drug effects | HIV-1 - drug effects | HIV-1 - genetics | CD8 Antigens - immunology | Immunity, Cellular - immunology | Immunity, Innate - immunology | HIV-1 - immunology | Animals | Simian Acquired Immunodeficiency Syndrome - drug therapy | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Viral - immunology | Simian Immunodeficiency Virus - drug effects | Viral antibodies | Antiviral agents | Antibodies | Toll-like receptors | Dosage and administration | Drug therapy | Health aspects | HIV infection | Antiretroviral drugs | Lymphatic system | Immunoglobulins | TLR7 protein | CD8 antigen | Viruses | Infections | Monkeys | Adoptive transfer | Antiretroviral therapy | Glycan | Proteins | Depletion | Antiretroviral agents | Human immunodeficiency virus--HIV | Antiviral activity | Binding sites | Deoxyribonucleic acid--DNA | Immune system
Journal Article
The Lancet, ISSN 0140-6736, 07/2018, Volume 392, Issue 10143, pp. 232 - 243
More than 1·8 million new cases of HIV-1 infection were diagnosed worldwide in 2016. No licensed prophylactic HIV-1 vaccine exists. A major limitation to date... 
MEDICINE, GENERAL & INTERNAL | IPCAVD 001 | IMMUNOGENICITY | SAFETY | EFFICACY TRIAL | CELLULAR IMMUNE-RESPONSES | SIV CHALLENGES | ENV VACCINE | PREVENTION | INFECTION | PROTECTIVE EFFICACY | Back Pain - etiology | Abdominal Pain - etiology | Adenoviridae | Double-Blind Method | Aspartate Aminotransferases - analysis | Humans | Middle Aged | Fatigue - etiology | Macaca mulatta | Healthy Volunteers | AIDS Vaccines - adverse effects | Dose-Response Relationship, Drug | Young Adult | Dizziness - etiology | HIV-1 - immunology | Animals | Immunity, Humoral | Adolescent | Adult | Diarrhea - etiology | AIDS Vaccines - administration & dosage | Genetic Vectors | Immunity, Cellular | Clinical trials | Product development | Vaccines | HIV (Viruses) | Back pain | Pandemics | Laboratories | Aluminum | Viruses | Lymphocytes T | Monkeys | Infections | Dosage | Posture | Proteins | Prevention | Randomization | Pain | Gag protein | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Peripheral blood | Safety | Pharmaceutical industry | Vaccinia | Enzyme-linked immunosorbent assay | Binding | Antigens | Medical research | Phenotypes | Immune response | Effectiveness | Health risks | Diarrhea | Durability | Studies | Immunogenicity | Adenoviruses | Federal agencies | Aspartate aminotransferase | Phagocytosis
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 1, pp. 1 - 9
Journal Article
Science, ISSN 0036-8075, 09/2019, Volume 365, Issue 6457, pp. 1029 - 1033
Sustained virologic control of human immunodeficiency virus type 1 (HIV-1) infection after discontinuation of antiretroviral therapy (ART) is a major goal of... 
Antiretroviral drugs | Therapy | Antidotes | Glycoprotein | Antibodies | Chronic infection | Viruses | Stop codon | Infections | Antiretroviral therapy | Infusion | Nef protein | Antiretroviral agents | Human immunodeficiency virus--HIV | Remission | Drug therapy
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 2011, Volume 82, Issue 8, pp. 1034 - 1035
Journal Article
Science Translational Medicine, ISSN 1946-6234, 12/2017, Volume 9, Issue 420, p. eaao4163
An effective Zika virus (ZIKV) vaccine will require long-term durable protection. Several ZIKV vaccine candidates have demonstrated protective efficacy in... 
PATHOGENESIS | MEDICINE, RESEARCH & EXPERIMENTAL | CHALLENGE | IMMUNITY | EFFICACY | ENHANCEMENT | CROSS-REACTIVITY | INFECTION | MACAQUES | MODEL | DENGUE VIRUS | CELL BIOLOGY
Journal Article
Nature, ISSN 0028-0836, 12/2018, Volume 564, Issue 7734, pp. E8 - E8
In Fig. 4b of this Article, the x-axis labels 'PGT121' and 'GS-9620' were inadvertently swapped in both graphs. In Fig. 5a, b, 'TLR7' should have been... 
Viral antibodies | Antibodies | Vaccines
Journal Article